RETRACTED Regulation of MAP Kinase-Directed Mitogenic and Protein Kinase B-Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells

Keyphrases

• Mitogen-activated Protein Kinase 100%
• Protein Kinase B 100%
• Skeletal muscle Cells 100%
• Cannabinoid Receptor 1 (CB1R) 100%
• Skeletal muscle 80%
• Endocannabinoid System 80%
• Insulin Sensitivity 40%
• Extracellular Signal-regulated Kinase 1/2 40%
• Kinase Protein 40%
• Diabetes 20%
• Energy Balance 20%
• Phosphoinositide 3-kinase (PI3K) 20%
• Liver 20%
• Rodents 20%
• Insulin 20%
• Pharmacological Inhibitors 20%
• Glucose Uptake 20%
• Adipose Tissue 20%
• Insulin Independence 20%
• Lipid Metabolism 20%
• Pancreatic β-cells 20%
• Type I Receptor 20%
• Glucose Metabolism 20%
• Lipogenesis 20%
• Inverse Agonist 20%
• Differential Effects 20%
• Receptor Activity 20%
• Feeding Behavior 20%
• Metabolic Signaling 20%
• Protein Kinase B Pathway 20%
• Insulin Release 20%
• Pharmacological Activation 20%
• Cell Uptake 20%
• Muscle Differentiation 20%
• Co-agonist 20%
• Neuromodulatory Systems 20%
• Endogenous Cannabinoid System 20%
• Mitogenic Signaling 20%
• Peripheral Mechanisms 20%
• Muscle Growth 20%
• Metabolically Active 20%

Medicine and Dentistry

• Skeletal Muscle Cell 100%
• Mitogen-Activated Protein Kinase 100%
• Protein Kinase B 100%
• Cannabinoid Receptor 100%
• Endocannabinoid System 80%
• Skeletal Muscle 80%
• Receptor 40%
• Phosphotransferase 40%
• Kinase 40%
• Phosphoinositide 3-Kinase 40%
• Insulin Sensitivity 40%
• Diabetes 20%
• Glucose Uptake 20%
• Adipose Tissue 20%
• Energy Balance 20%
• Beta Cell 20%
• Lipid Metabolism 20%
• Lipogenesis 20%
• Insulin Release 20%
• Endocannabinoid 20%
• Glucose Metabolism 20%
• Synapsin II 20%
• Inverse Agonist 20%
• Agonist-Antagonist 20%
• Muscle Development 20%
• Cell Signaling Pathway 20%
• Muscle Growth 20%